ISB 2001, a first-in-class trispecific antibody developed by IGI, showed a 79% response rate in relapsed/refractory multiple ...

COVID-19 vaccine protection fades within months due to a lack of long-lived plasma cells. Booster shots restore some immunity ...

Plasma therapy is one of several different experimental longevity procedures that involve blood transfers, including platelet ...

A type of white blood cell called a plasma cell makes antibodies that fight infections in your body. When you have multiple myeloma, these cells multiply the wrong way. They let too much protein ...

The role of antigens and antibodies in vaccinations Vaccines contain antigens that stimulate the B lymphocytes of the immune system to respond by producing plasma cells which secrete disease-specific ...

a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s exclusive ...

Researchers discover that COVID-19 mRNA vaccines do not generate long-lasting plasma cells in the bone marrow, shedding light on why antibody immunity wanes quickly, and highlighting the urgent ...

Plasma cells originate in lymphoid (immune) tissues and then migrate to protected sites throughout the body, where they produce large amounts of antibodies in response to infection-related substances.

B cells help activate T cells, but also produce antibodies against infections. These B or plasma cells work to neutralize foreign substances and allow the body to maintain homeostasis. Both T and B ...

“One challenge we encountered was that the bispecific antibody used for killing tumor cells can also bind the engineered plasma B cells because they express the same target protein,” James stated.

Myeloma is a type of blood cancer that develops from plasma cells in the bone marrow. Plasma cells are a type of blood cell that makes antibodies to fight infection. The bone marrow makes them. In ...